-+ 0.00%
-+ 0.00%
-+ 0.00%

SATELLOS RECEIVES CLEARANCE BY U.S. FDA AND GLOBAL REGULATORS TO INITIATE PEDIATRIC PHASE 2 STUDY OF SAT-3247 FOR DUCHENNE MUSCULAR DYSTROPHY

Reuters·12/09/2025 12:00:00

Please log in to view news